Comparison of synovial MMP-1 and TIMP-1 levels in patients with various inflammatory arthritides: Is there any difference between rheumatoid arthritis, Behçet's disease and familial mediterranean fever?

Clinical Rheumatology

Volumn 21, Issue 6, 2002, Pages 511-515

  Pay, Salih ^a   Erdem, H ^a   Serdar, M ^a   Dinc A ^a   Simsek I ^a   Turan, M ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Beh et's disease; Familial mediterranean fever; MMP 1; Osteoarthritis; Rheumatoid arthritis; TIMP 1

Indexed keywords

C REACTIVE PROTEIN; COLLAGEN; CYTOKINE; INTERSTITIAL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; BEHCET DISEASE; CLINICAL OBSERVATION; COLLAGEN DEGRADATION; CONTROLLED STUDY; DISEASE MARKER; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM;

ADULT; ARTHRITIS, RHEUMATOID; BEHCET SYNDROME; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; OSTEOARTHRITIS; SYNOVIAL MEMBRANE; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0036870578     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670200125     Document Type: Article

References (27)

1. Cawston T. Tissue destruction and repair. In: Klippel JH, Dieppe PA, eds. Rheumatology. London: Mosby, 1998:1.8.1.
2. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsoson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997;74:11-2.
3. Firestein GS. Rheumatoid synovitis and pannus. In: Klippel JH, Dieppe PA, eds. Rheumatology. London: Mosby, 1998:5.13.16.
4. International Study Group For Behcet Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990;335:1078-80.
5. Livneh A, Langevitz P, Zemer D. Criteria for the diagnosis of familial Mediterranian fever. Arthritis Rheum 1997;40:1879-85.
6. Calabrese LH, Michel BA, Bloch DA. The American Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis. Arthritis Rheum 1990;33:1108-13.
7. Altman RD. Criteria for classification of clinical osteoarthritis. J Rheumatol 1991;18:10-2.
8. Konttinen YT, Ainola M, Valleala H et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999;158:691-7.
9. Lohmander LS, Hoerrner LA, Lark MW. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum 1993;36:181-9.
10. Ishiguro N, Ito T, Ito H et al. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover. Arthritis Rheum 1999;42:129-36.
11. Yoshihara Y, Nakamura H, Obata K et al. Matrix metalloproteinase and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 2000;59:455-61.
12. Kikuchi H, Shimada W, Nonaka T, Ueshima S, Tanaka S. Significance of serine proteinase and matrix metallproteinase systems in the destruction of human articular cartilage. Clin Exp Pharmacol Physiol 1996;23:885-9.
13. So T, Ito A, Sato T, Mori Y, Hirakawa S. Tumor necrosis factor-alpha stimulates the biosynthesis of matrix metalloproteinases and plasminogen activator in cultured human chorionic cell. Biol Reprod 1992;46:772-8.
14. Rawdanowicz TJ, Hampton AL, Nagase H, Wooley DE, Salomonsen DA. Matrix metalloproteinase production by cultured human endometrial stromal cell: identification of interstitial collagenase, gelatinase a, gelatinase b, and stromelysin-1 and their different regulation by interleukin-1 beta and tumor necrosis factor-alpha. J Clin Endocrinol Metab 1994; 79:530-6.
15. Richardson DW, Dodge GR. Effects of interleukin-1 beta and tumor necrosis factor-alpha on expression of matrix related genes by cultured equine articular condrocytes. Am J Vet Res 2000; 61:624-30.
16. Akoglu TF, Direskeneli H, Yazici H, Lawrence R. TNF, soluble IL-2R and soluble CD-8 in Behcet disease. J Rheumatol 1990;17:1107-8.
17. Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaroglu IC, Dundar S, Kirazli S. Cytokines in Behcet's disease. J Rheumatol 1996; 23:321-2.
18. Ertenli I, Kiraz S, Calguneri M et al. Synovial fluid cytokine levels in Behcet's disease.: Clin Exp Rheumatol 2001;19(Suppl 24):S37-41.
19. Özyilkan E, Şimşek H, Telatar H. Tumor necrosis factor in FMF. Am J Med 1992;92:579-83.
20. Schattner A, Lachmi M, Hahn T et al. Tumor necrosis factor in FMF. Am J Med Genet 1992;44:179-82.
21. Schattner A, Lachmi M, Livney A, Pras M, Hahn T. Tumor necrosis factor in FMF. Am J Med 1991;90:434-8.
22. Kiraz S, Ertenli I, Arici M et al. Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean Fever. Clin Exp Rheumatol 1998;16:721-4.
23. Ribbens C, Andre B, Kaye O et al. Fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or not. Rheumatology 2000;39:1357-65.
24. Naito K, Takahashi M, Kushida K et al. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis. Rheumatology 1999;38:510-5.
25. Nawrocki B, Polette M, Clavel C et al. Expression of stromelysin 3 and tissue inhibitors of matrix metalloproteinases, TIMP-1 and TIMP-2 in rheumatoid arthritis. Pathol Res Pract 1994;190:690-6.
26. Kageyama Y, Miyamoto S, Ozeki T, Hiyoshi M, Suzuki M, Nagano A. Levels of rheumatoid factor isotypes, metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in synovial fluid from various arthritides. Clin Rheumatol 2000;19:14-20.
27. Ishiguro N, Ito T, Miyazaki K, Iwata H. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and glycosaminoglycans in synovial fluid from patients with rheumatoid arthritis. J Rheumatol 1999;26:34-40.